Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Revenue

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹7,896 Cr₹6,658 Cr₹5,986 Cr₹5,855 Cr₹6,056 Cr

What is the latest Revenue of EMCURE PHARMACEUTICALS ?

The latest Revenue ratio of EMCURE PHARMACEUTICALS is ₹7,896 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹7,896 Cr
Mar2024₹6,658 Cr
Mar2023₹5,986 Cr
Mar2022₹5,855 Cr
Mar2021₹6,056 Cr

How is Revenue of EMCURE PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹7,896 Cr
18.59
Mar2024 ₹6,658 Cr
11.23
Mar2023 ₹5,986 Cr
2.23
Mar2022 ₹5,855 Cr
-3.32
Mar2021 ₹6,056 Cr -

Compare Revenue of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹33,653.7 Cr 4.1% 2.4% 28.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,794.0 Cr 1.7% -2.3% 8% Stock Analytics
DIVIS LABORATORIES ₹178,956.0 Cr 2% -2.2% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,820.0 Cr -1.8% -0.1% 36.7% Stock Analytics
CIPLA ₹109,370.0 Cr -2% -3.3% -9.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,133.0 Cr -0.6% -3.8% -6.9% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

4.1%

2.4%

28.6%

SENSEX

1.7%

2.1%

-6%


You may also like the below Video Courses